Welcome to Elekta, the global human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders.
Elekta aims to provide access to all relevant information for media professionals and our investors. Investors can find the latest press releases, financial reports and can also monitor our share price using our interactive graph. Media Professionals can download images of our products and management team and access articles and other resources in our Media Resources area.
With approximately 3,500 employees, Elekta’s corporate headquarters are located in Stockholm, Sweden and the company is listed on the Nordic Stock Exchange under the ticker EKTAb.
Elekta AB (Publ)
SE-103 93 Stockholm
REg. No: 556170-4015